Inhibrx Biosciences, Inc. (INBX)
109.35
+4.62
(+4.41%)
USD |
NASDAQ |
Sep 18, 16:00
109.58
+0.23
(+0.21%)
Pre-Market: 20:00
Inhibrx Biosciences 1 Year Total Returns (Daily) : 310.3% for Sept. 18, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 18, 2026 | 310.3% |
| September 17, 2026 | 294.7% |
| September 16, 2026 | 283.0% |
| September 15, 2026 | 288.5% |
| September 14, 2026 | 301.4% |
| September 11, 2026 | 284.1% |
| September 10, 2026 | 303.0% |
| September 09, 2026 | 281.5% |
| September 08, 2026 | 292.9% |
| September 04, 2026 | 337.1% |
| September 03, 2026 | 339.8% |
| September 02, 2026 | 352.5% |
| September 01, 2026 | 342.1% |
| August 31, 2026 | 349.3% |
| August 28, 2026 | 342.6% |
| August 27, 2026 | 352.3% |
| August 26, 2026 | 383.7% |
| August 25, 2026 | 390.1% |
| August 24, 2026 | 319.8% |
| August 21, 2026 | 328.9% |
| August 20, 2026 | 306.2% |
| August 19, 2026 | 341.2% |
| August 18, 2026 | 296.4% |
| August 17, 2026 | 294.4% |
| August 14, 2026 | 269.1% |
| Date | Value |
|---|---|
| August 13, 2026 | 311.6% |
| August 12, 2026 | 348.7% |
| August 11, 2026 | 331.7% |
| August 10, 2026 | 342.1% |
| August 07, 2026 | 315.5% |
| August 06, 2026 | 308.9% |
| August 05, 2026 | 300.7% |
| August 04, 2026 | 283.2% |
| August 03, 2026 | 283.0% |
| July 31, 2026 | 274.3% |
| July 30, 2026 | 268.6% |
| July 29, 2026 | 226.7% |
| July 28, 2026 | 224.3% |
| July 27, 2026 | 257.2% |
| July 24, 2026 | 253.5% |
| July 23, 2026 | 266.4% |
| July 22, 2026 | 275.9% |
| July 21, 2026 | 296.1% |
| July 20, 2026 | 243.9% |
| July 17, 2026 | 270.0% |
| July 16, 2026 | 276.6% |
| July 15, 2026 | 297.3% |
| July 14, 2026 | 306.0% |
| July 13, 2026 | 323.4% |
| July 10, 2026 | 343.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| AnaptysBio, Inc. | 292.8% |
| 4D Molecular Therapeutics, Inc. | 114.4% |
| Design Therapeutics, Inc. | 95.84% |
| Agenus, Inc. | 72.53% |
| Amgen, Inc. | 43.68% |